Skip to navigation Skip to content



The Transition to Secondary Progressive MS: Meeting the Challenge

February 18, 2020

Some people who are diagnosed with relapsing-remitting MS will transition to a secondary progressive (SP) course in which there are fewer or no relapses and  a progressive change in neurologic function (accumulation of disability) over time. This can be a time of uncertainty and worry about how MS may change function or affect life plans. Dr. Jiwon Oh discusses the challenges and provides strategies for managing this transition in an interview posted on Neuro Central.
Patient empowerment is key to this transition, notes Dr. Oh and it is through “a strong patient–physician relationship that is built on open communication” that treatment plans can be optimized to improve the lives of people with MS. In a recent review, Dr. Oh and colleagues describe strategies that healthcare providers can use to help individuals manage secondary progressive MS. Dr. Oh has high hopes for the field of progressive MS and believes that there will be substantial advancements in our understanding, and subsequently, the ways we treat and monitor progressive MS in the future.
Read about strategies for coping with the transitions to secondary progressive MS

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system. Symptoms range from numbness and tingling to blindness and paralysis, and there is currently no cure for MS. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. An estimated 1 million people live with MS in the United States. Most people with MS are diagnosed between the ages of 20 and 50, and it affects women three times more than men.


© 2023 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.